Leigh Vosseller Insider Trading $TNDM TANDEM DIABETES CARE INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Leigh Vosseller.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Leigh Vosseller. Leigh Vosseller is EVP & CHIEF FINANCIAL OFFICER in TANDEM DIABETES CARE INC ($TNDM) and EVP and CFO in TANDEM DIABETES CARE INC ($TNDM).
Leigh Vosseller in TANDEM DIABETES CARE INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Leigh Vosseller: EVP & CHIEF FINANCIAL OFFICER, EVP and CFO
Holdings: 6,442 shares
Current Value: $15,461
Latest Transaction: Jun 01 2021
$TNDM Market Capitalization: $70.48M
$TNDM Previous Close: $2.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Leigh Vosseller in TANDEM DIABETES CARE INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 0.00 | 1,626 | 0 | 4,878 | |
| Jun 01 2021 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Payment of Exercise | F | 85.65 | 563 | 48,221 | 5,879 | 6.4 K to 5.9 K (-8.74 %) |
| Jun 01 2021 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 0.00 | 1,626 | 0 | 6,442 | 4.8 K to 6.4 K (+33.76 %) |
| Oct 15 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 18.86 | 10,000 | 188,600 | 65,160 | |
| Oct 15 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 122.33 | 1,022 | 125,018 | 4,520 | 5.5 K to 4.5 K (-18.44 %) |
| Oct 15 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 121.57 | 2,580 | 313,645 | 5,542 | 8.1 K to 5.5 K (-31.77 %) |
| Oct 15 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 120.36 | 6,398 | 770,065 | 8,122 | 14.5 K to 8.1 K (-44.06 %) |
| Oct 15 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 18.86 | 10,000 | 188,600 | 14,520 | 4.5 K to 14.5 K (+221.24 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 18.86 | 10,000 | 188,600 | 75,160 | |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 110.03 | 10,000 | 1,100,319 | 4,520 | 14.5 K to 4.5 K (-68.87 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 18.86 | 10,000 | 188,600 | 14,520 | 4.5 K to 14.5 K (+221.24 %) |
| Jul 07 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 18.86 | 10,000 | 188,600 | 85,160 | |
| Jul 07 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 105.04 | 10,000 | 1,050,387 | 4,520 | 14.5 K to 4.5 K (-68.87 %) |
| Jul 07 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 18.86 | 10,000 | 188,600 | 14,520 | 4.5 K to 14.5 K (+221.24 %) |
| Jul 02 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 18.86 | 4,840 | 91,282 | 95,160 | |
| Jul 02 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 9.00 | 5,160 | 46,440 | 2,340 | |
| Jul 02 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 0 | |
| Jul 02 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 101.13 | 1,738 | 175,763 | 4,520 | 6.3 K to 4.5 K (-27.77 %) |
| Jul 02 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 18.86 | 1,738 | 32,779 | 6,258 | 4.5 K to 6.3 K (+38.45 %) |
| Jul 02 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 100.29 | 8,262 | 828,593 | 4,520 | 12.8 K to 4.5 K (-64.64 %) |
| Jul 02 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 9.00 | 8,262 | 74,358 | 12,782 | 4.5 K to 12.8 K (+182.79 %) |
| Jul 02 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 95.04 | 10,000 | 950,394 | 4,520 | 14.5 K to 4.5 K (-68.87 %) |
| Jul 02 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 2.59 | 10,000 | 25,900 | 14,520 | 4.5 K to 14.5 K (+221.24 %) |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | A | 82.34 | 15,012 | 1,236,088 | 15,012 | |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | A | 0.00 | 6,504 | 0 | 6,504 | |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | A | 82.34 | 15,012 | 1,236,088 | 15,012 | |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | A | 0.00 | 6,504 | 0 | 6,504 | |
| May 19 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Grant | A | 16.93 | 1,255 | 21,247 | 4,520 | 3.3 K to 4.5 K (+38.44 %) |
| May 08 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 10,000 | |
| May 08 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 90.07 | 10,000 | 900,746 | 3,265 | 13.3 K to 3.3 K (-75.39 %) |
| May 08 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 2.59 | 10,000 | 25,900 | 13,265 | 3.3 K to 13.3 K (+306.28 %) |
| Feb 12 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 2.59 | 3,626 | 9,391 | 20,000 | |
| Feb 12 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 2.59 | 6,374 | 16,509 | 23,626 | |
| Feb 12 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 80.00 | 3,626 | 290,080 | 3,265 | 6.9 K to 3.3 K (-52.62 %) |
| Feb 12 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 2.59 | 3,626 | 9,391 | 6,891 | 3.3 K to 6.9 K (+111.06 %) |
| Feb 12 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 80.06 | 6,374 | 510,273 | 3,265 | 9.6 K to 3.3 K (-66.13 %) |
| Feb 12 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 2.59 | 6,374 | 16,509 | 9,639 | 3.3 K to 9.6 K (+195.22 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 30,000 | |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 76.31 | 383 | 29,227 | 3,265 | 3.6 K to 3.3 K (-10.50 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 2.59 | 383 | 992 | 3,648 | 3.3 K to 3.6 K (+11.73 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 75.91 | 9,617 | 730,026 | 3,265 | 12.9 K to 3.3 K (-74.65 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 2.59 | 9,617 | 24,908 | 12,882 | 3.3 K to 12.9 K (+294.55 %) |
| Nov 26 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 40,000 | |
| Nov 26 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 70.35 | 10,000 | 703,500 | 3,265 | 13.3 K to 3.3 K (-75.39 %) |
| Nov 26 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 2.59 | 10,000 | 25,900 | 13,265 | 3.3 K to 13.3 K (+306.28 %) |
| Nov 18 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 50,000 | |
| Nov 18 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 66.11 | 1,700 | 112,387 | 3,265 | 5 K to 3.3 K (-34.24 %) |
| Nov 18 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Sell | S | 65.27 | 8,300 | 541,741 | 4,965 | 13.3 K to 5 K (-62.57 %) |
| Nov 18 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP & CHIEF FINANCI ... | Buy | M | 2.59 | 10,000 | 25,900 | 13,265 | 3.3 K to 13.3 K (+306.28 %) |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Option Exercise | M | 2.59 | 10,000 | 25,900 | 60,000 | |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Grant | A | 16.93 | 1,256 | 21,264 | 3,265 | 2 K to 3.3 K (+62.52 %) |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Sell | S | 70.45 | 10,000 | 704,500 | 2,009 | 12 K to 2 K (-83.27 %) |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Buy | M | 2.59 | 10,000 | 25,900 | 12,009 | 2 K to 12 K (+497.76 %) |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Option Exercise | M | 2.59 | 10,000 | 25,900 | 60,000 | |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Grant | A | 16.93 | 1,256 | 21,264 | 3,265 | 2 K to 3.3 K (+62.52 %) |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Sell | S | 70.45 | 10,000 | 704,500 | 2,009 | 12 K to 2 K (-83.27 %) |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Buy | M | 2.59 | 10,000 | 25,900 | 12,009 | 2 K to 12 K (+497.76 %) |
| May 06 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Option Exercise | M | 2.59 | 10,000 | 25,900 | 70,000 | |
| May 06 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Sell | S | 65.14 | 10,000 | 651,400 | 2,009 | 12 K to 2 K (-83.27 %) |
| May 06 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Buy | M | 2.59 | 10,000 | 25,900 | 12,009 | 2 K to 12 K (+497.76 %) |
| Feb 20 2019 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Option Exercise | A | 51.50 | 105,000 | 5,407,500 | 105,000 | |
| Nov 19 2018 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Grant | A | 16.92 | 1,255 | 21,235 | 2,145 | 890 to 2.1 K (+141.01 %) |
| Jun 15 2018 | TNDM | TANDEM DIABETES CA ... | Vosseller Leigh | EVP and CFO | Option Exercise | A | 18.86 | 100,000 | 1,886,000 | 100,000 |
Page: 1